Pay in 4 interest-free payments of $7.34 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
(PubMed) Speckmann B, Steinbrenner H
News/Blogs GLP-1 Advertising Boom Puts Spotlight on PBMs to Promote Appropriate Utilization Pharmaceutical direct-to-consumer advertising (DTCA) is a controversial practice banned in most countries but allowed in the United States and New Zealand
He said larger studies are needed to determine whether the effects persist after treatment ends and whether they apply to people who do not need GLP-1 medications for conditions such as obesity or diabetes
The program aims to close a longstanding gap in Medicare coverage, as these medications have historically been excluded when prescribed solely for weight loss
US$ 25.47
US$ 20.04
US$ 27.53
US$ 28.02
US$ 28.83
US$ 21.66
US$ 28.42
US$ 25.20
US$ 22.49
US$ 26.07
US$ 21.45
